Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K0706 in early Parkinson's disease
2018-003337-15Phase 2Terminated
- Sponsor
- Sun Pharma Advanced Research Company
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing K0706 with Placebo (2 arms). Primary endpoint: Change from baseline to Week 40 in the sum of MDS-UPDRS Parts 2 and 3. Started Apr 2019; status: terminated.
02
Drugs
vodobatinib
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2018-003337-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003337-15.